Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19

BACKGROUND: Approximately 13.8% and 6.1% of coronavirus disease 2019 (COVID-19) patients require hospitalization and sometimes intensive care unit (ICU) admission, respectively. There is no biomarker to predict which of these patients will develop an aggressive stage that we could improve their qual...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Diz, Silvia, Marín-Benesiu, Fernando, López-Torres, Ginesa, Santiago, Olivia, Díaz-Cuéllar, José F., Martín-Esteban, Sara, Cortés-Valverde, Ana I., Arenas-Rodríguez, Verónica, Cuenca-López, Sergio, Porras-Quesada, Patricia, Ruiz-Ruiz, Carmen, Abadía-Molina, Ana C., Entrala-Bernal, Carmen, Martínez-González, Luis J., Álvarez-Cubero, Maria Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031647/
https://www.ncbi.nlm.nih.gov/pubmed/36969980
http://dx.doi.org/10.3389/fimmu.2022.1094644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031647/
https://www.ncbi.nlm.nih.gov/pubmed/36969980
http://dx.doi.org/10.3389/fimmu.2022.1094644

Ejemplares similares